Our white paper provides an overview of pharmacogenomics (PGx) and its vital role in understanding how genetic variations affect an individual’s response to drugs. Highlights include the importance of PGx in supporting personalized medicine initiatives post approval, and focusing on the pivotal role it plays in enhancing drug safety and efficacy within clinical trials. Download our white paper today to learn more:
Authors:
Tom Zhang, PhD.
Chief Scientific Officer, Large Molecule Bioanalysis
Sherilyn Adcock, RPh, PhD
Chief Scientific Officer, Early Phase Development
